During a discussion about the future direction of immuno-oncology pharmaceuticals at the Annual ChinaBio® Partnering Meeting held in Suzhou, China, last May, one point of disagreement among the panelists was whether the number of Chinese companies targeting development…
China’s Pharmaceutical “Sea Turtles” – Innovation or Imitation and Does It Matter?

December 13, 2016 | Category: Blog | Tags: China CMO, China Fill Finish, Chinese CMO, PaizaBio, Sea Turtles